[HTML][HTML] Opioid analgesia and opioid-induced adverse effects: a review

AK Paul, CM Smith, M Rahmatullah, V Nissapatorn… - Pharmaceuticals, 2021 - mdpi.com
Opioids are widely used as therapeutic agents against moderate to severe acute and
chronic pain. Still, these classes of analgesic drugs have many potential limitations as they …

[HTML][HTML] Pharmacological interventions for opioid-induced hyperalgesia: a scoping review of preclinical trials

ME Koponen, P Forget - Journal of Clinical Medicine, 2022 - mdpi.com
Background: Opioid analgesics are the most effective pharmacological agents for moderate
and severe pain. However, opioid use has several limitations such as opioid-induced …

Mu opioid receptor in microglia contributes to morphine analgesic tolerance, hyperalgesia, and withdrawal in mice

D Reiss, T Maduna, H Maurin… - Journal of …, 2022 - Wiley Online Library
A major challenge in medicine is developing potent pain therapies without the adverse
effects of opiates. Neuroinflammation and in particular microglial activation have been …

OFP011 cyclic peptide as a multifunctional agonist for opioid/neuropeptide ff receptors with improved blood–brain barrier penetration

M Zhang, B Xu, N Li, R Zhang, Q Zhang… - ACS Chemical …, 2022 - ACS Publications
Mounting evidence indicates that the neuropeptide FF (NPFF) system is involved in the side
effects of opioid usage, including antinociceptive tolerance, hyperalgesia, abuse …

Neuropeptide FF and its receptors: therapeutic applications and ligand development

T Nguyen, J Marusich, JX Li… - Journal of medicinal …, 2020 - ACS Publications
The endogenous neuropeptide FF (NPFF) and its two cognate G protein-coupled receptors,
Neuropeptide FF Receptors 1 and 2 (NPFFR1 and NPFFR2), represent a relatively new …

[HTML][HTML] Influence of G protein-biased agonists of μ-opioid receptor on addiction-related behaviors

L Kudla, R Przewlocki - Pharmacological Reports, 2021 - Springer
Opioid analgesics remain a gold standard for the treatment of moderate to severe pain.
However, their clinical utility is seriously limited by a range of adverse effects. Among them …

Inhibition of Hsp90 in the spinal cord enhances the antinociceptive effects of morphine by activating an ERK-RSK pathway

DI Duron, W Lei, NK Barker, C Stine, S Mishra… - Science …, 2020 - science.org
Morphine and other opioids are commonly used to treat pain despite their numerous
adverse side effects. Modulating μ-opioid receptor (MOR) signaling is one way to potentially …

Biodegradable amphipathic peptide hydrogels as extended-release system for opioid peptides

C Martin, M Dumitrascuta, M Mannes… - Journal of medicinal …, 2018 - ACS Publications
Chronic pain is currently treated with opioids that offer unsatisfactory long-term analgesia
and produce serious side effects. There is a clear need for alternative therapies. Herein …

The effect of combination of spiritual deep breathing exercise therapy on pain and anxiety in postoperative nonpatological orthopedic fracture patients.

A Yusuf, MF Iswari, S Sriyono… - EurAsian Journal of …, 2020 - search.ebscohost.com
Acute pain and anxiety at the severe level because of postoperative orthopedic fractures of
nonpathological causes high analgesic demand in patients. It causes a high risk of side …

[HTML][HTML] Bifunctional peptidomimetic G protein-biased mu-opioid receptor agonist and neuropeptide FF receptor antagonist KGFF09 shows efficacy in visceral pain …

M Dumitrascuta, C Martin, S Ballet, M Spetea - Molecules, 2022 - mdpi.com
There is still an unmet clinical need to develop new pharmaceuticals for effective and safe
pain management. Current pharmacotherapy offers unsatisfactory solutions due to serious …